Cancer incidence and mortality in France over the period 1980-2005

Revue d'Epidemiologie et de Sante Publique

Volumn 56, Issue 3, 2008, Pages 159-175

  Belot, A ^a,b,c,d   Grosclaude, P ^e   Bossard, N ^a,b,c   Jougla, E ^f   Benhamou, E ^g   Delafosse, P ^e   Guizard, A V ^e   Molinie F ^e   Danzon, A ^e   Bara, S ^e   Bouvier, A M ^e   Tretarre B ^e   Binder Foucard, F ^e   Colonna, M ^e   Daubisse, L ^e   Hedelin G ^e   Launoy, G ^e   Le Stang, N ^e   Maynadie M ^e   Monnereau, A ^e   Troussard, X ^e   Faivre, J ^e   Collignon, A ^e   Janoray, I ^e   Arveux, P ^e   Buemi, A ^e   Raverdy, N ^e   Schvartz, C ^e   Bovet, M ^f   Cherie Challine L ^d   Esteve J ^a,b,c   Remontet, L ^a,b,c   Velten, M ^e   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e Registre des cancers du Tarn ^*  (France)

^f INSERM   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer; Incidence; Mortality; Registry; Trends

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; FRANCE; LUNG CANCER; PROSTATE CANCER;

FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; NEOPLASMS; REGISTRIES;

EID: 46949090897     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respe.2008.03.117     Document Type: Article

References (56)

1. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51 1 Pt 1 (2003) 3-30
2. Bossard N., Velten M., Remontet L., Belot A., Maarouf N., Bouvier A.M., et al. Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43 1 (2007) 149-160
3. Hill C., and Doyon F. Age in completed years versus age reached during the year. Rev Epidemiol Sante Publique 53 2 (2005) 205-208
4. Clayton D., and Schifflers E. Models for temporal variation in cancer rates. I: Age-Period and Age-Cohort models. Stat Med 6 (1987) 449-467
5. Clayton D., and Schifflers E. Models for temporal variation in cancer rates. II. Age-Period- Cohort models. Stat Med 6 (1987) 469-481
6. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Descriptive epidemiology. IARC, Press, 1994.
7. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 19 14 (2000) 1831-1847
8. Hastie T., and Tibshirani R. Generalized additive models (1995), Chapman and Hall, London, New York
9. Green P.J., and Silverman B.W. Nonparametric regression and generalized linear models: a rougness penalty approach. (1994), Chapman and Hall, London
10. Curado.M.P., Edwards B, Shin.H.R., Storm.H., Ferlay.J., Heanue.M. et al. Cancer incidence in five continents, vol. 9 2007 ed. Lyon: IARC Scientific Publications No. 160, 2007.
11. Hill C., Benhamou E., and Doyon F. Trends in cancer mortality, France 1950-1985. Br J Cancer 63 4 (1991) 587-590
12. Desoubeaux N., Le Prieur A., Launoy G., Maurel J., Lefevre H., Guillois J.M., et al. Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: a population based study. Eur J Cancer Prev 8 6 (1999) 479-486
13. Lepage C., Bouvier A.M., Manfredi S., Coatmeur O., Cheynel N., and Faivre J. Trends in incidence and management of esophageal adenocarcinoma in a well-defined population. Gastroenterol Clin Biol 29 12 (2005) 1258-1263
14. Bouvier A.M., Esteve J., Mitry E., Clinard F., Bonithon-Kopp C., and Faivre J. Trends in gastric cancer incidence in a well-defined French population by time period and birth cohort. Eur J Cancer Prev 11 3 (2002) 221-227
15. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 3 (2007) 581-592
16. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., Manfredi S., Dancourt V., and Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 51 1 (2002) 60-64
17. Devesa S.S., Blot W.J., Stone B.J., Miller B.A., Tarone R.E., and Fraumeni Jr. J.F. Recent cancer trends in the United States. J Natl Cancer Inst 87 3 (1995) 175-182
18. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol 8. IARC ed. Lyon: Scientific Publication, 2002.
19. Bugianesi E., Vanni E., and Marchesini G. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Curr Diab Rep 7 3 (2007) 175-180
20. Sturgis E.M., and Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110 7 (2007) 1429-1435
21. Janssen-Heijnen M.L., and Coebergh J.W. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 31 2-3 (2001) 123-137
22. Saika K, Matsuda T. Comparison of time trends in lung cancer incidence (1973 97) in East Asia, Europe and USA, from Cancer incidence in five continents vols 4,8. Jpn J Clin Oncol 2007; 37(6):474-476.
23. MacKie R.M., Bray C., Vestey J., Doherty V., Evans A., Thomson D., et al. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 96 11 (2007) 1772-1777
24. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; %20;107(1):119-126.
25. Stang A., Pukkala E., Sankila R., Soderman B., and Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer 119 2 (2006) 380-384
26. Lipsker D., Engel F., Cribier B., Velten M., and Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 157 2 (2007) 338-343
27. Jemal A., Ward E., and Thun M.J. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9 3 (2007) R28
28. Arbyn M., Autier P., and Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 18 8 (2007) 1423-1425
29. Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B. et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007; %19;99(24):1881-1887.
30. Moller H., Fairley L., Coupland V., Okello C., Green M., Forman D., et al. The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer 96 9 (2007) 1484-1488
31. Purdue M.P., Devesa S.S., Sigurdson A.J., and McGlynn K.A. International patterns and trends in testis cancer incidence. Int J Cancer 115 5 (2005) 822-827
32. Matsuda T., Remontet L., and Grosclaude P. Incidence of bladder cancer in France: trends from 1980 to 2000. Prog Urol 13 4 (2003) 602-607
33. Hayat M.J., Howlader N., Reichman M.E., and Edwards B.K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12 1 (2007) 20-37
34. Colonna M., Guizard A.V., Schvartz C., Velten M., Raverdy N., Molinie F., et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer 43 5 (2007) 891-900
35. Colonna M., Grosclaude P., Remontet L., Schvartz C., Masse-Lesech J., Velten M., et al. Incidence of thyroid cancer in adult recorded by French cancer registries (1978-1997). Eur J Cancer 38 (2002) 1762-1768
36. Leenhardt L., Grosclaude P., and Cherie-Challine L. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14 12 (2004) 1056-1060
37. Morton L.M., Turner J.J., Cerhan J.R., Linet M.S., Treseler P.A., Clarke C.A., et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110 2 (2007) 695-708
38. Adamson P., Bray F., Costantini A.S., Tao M.H., Weiderpass E., and Roman E. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43 2 (2007) 391-401
39. Alexander D.D., Mink P.J., Adami H.O., Chang E.T., Cole P., Mandel J.S., et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120 Suppl. 12 (2007) 1-39
40. La Vecchia C., Negri E., Levi F., Decarli A., and Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 34 1 (1998) 118-141
41. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 26 (2007) 3018-3045
42. Bashir S., and Esteve J. Analysing the difference due to risk and demographic factors for incidence or mortality. Int J Epidemiol 29 5 (2001) 878-884
43. Thompson IM, Ankerst DP. Prostate-specific antigen in the early detection of prostate cancer. CMAJ 2007; %19;176(13):1853-1858.
44. Bryant R.J., and Hamdy F.C. Screening for prostate cancer: an update. Eur Urol 53 1 (2008) 37-44
45. Ilic D., O'Connor D., Green S., and Wilt T. Screening for prostate cancer: a Cochrane systematic review. Cancer Causes Control 18 3 (2007) 279-285
46. Pashayan N., Powles J., Brown C., and Duffy S.W. Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. Br J Cancer 95 3 (2006) 401-405
47. Etzioni R., Penson D.F., Legler J.M., di Tommaso D., Boer R., Gann P.H., et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94 13 (2002) 981-990
48. de Koning H.J., Auvinen A., Berenguer S.A., Calais dS, Ciatto S., Denis L., et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97 2 (2002) 237-244
49. MacMahon B., Cole P., Lin T.M., Lowe C.R., Mirra A.P., Ravnihar B., et al. Age at first birth and breast cancer risk. Bull World Health Org 43 (1970) 20-9221
50. Allemand H., Seradour B., Weill A., and Ricordeau P. Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95 1 (2008) 11-15
51. Expertise Collective INSERM. Cancer - Approche méthodologique du lien avec l'environnement. 2005.
52. Olsen JH. Avoidable cancers in the Nordic countries. Aims and background. APMIS Suppl. 1997; 76:1-8.:1-8.
53. Danaei G, Vander HS, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; %19;366(9499):1784-1793.
54. Doll R., and Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66 6 (1981) 1191-1308
55. Salines G., Eilstein D., Le Moal J., Bloch J., and Imbernon E. Opinion on the issue: the causes of cancer in France. Rev Epidemiol Sante Publique 55 6 (2007) 423-424
56. Working Group. Attributable Causes of Cancer in France in the year 2000. Lyon: IARC Scientific Publications series, 2007.